OpenVSafe by OpenVAERS
Search V-safe

2MD-23602-04667

6 vaccinations 26 coded responses 68 check-ins 19 free-text entries 0 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
502 / IA
Registered
2021-02-10
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-10
    Registered in v-safe
  2. 2021-02-10
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-03
    Dose 2 — Pfizer-BioNTech
  4. 2021-03-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  5. 2021-03-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-03-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-03-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-03-10
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-03-17
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-03-24
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-03-31
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-04-07
    Survey response — day 35, dose 2
    MedDRA: Dizziness, Vertigo — Feeling: Good
    Free text: Experienced Vertigo when getting out of bed , but used Epley Maneuver to abate symptoms. After three days, Vertigo was completely gone, and no more dizziness.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-14
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-06-02
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-09-01
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-09-24
    Dose 3 — Pfizer-BioNTech
  17. 2021-09-24
    Survey response — day 0, dose 3
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2024-11 · check-in free text available
  18. 2021-09-25
    Survey response — days 1–6 daily, dose 3
    MedDRA: No adverse event — Feeling: Good · Site: Pain, Swelling
    Free text: None
    MedDRA releases: 2024-11 · check-in free text available
  19. 2021-09-26
    Survey response — days 1–6 daily, dose 3
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2024-11 · check-in free text available
  20. 2021-09-27
    Survey response — days 1–6 daily, dose 3
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2024-11 · check-in free text available
  21. 2021-09-28
    Survey response — days 1–6 daily, dose 3
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2024-11 · check-in free text available
  22. 2021-09-29
    Survey response — days 1–6 daily, dose 3
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2024-11 · check-in free text available
  23. 2021-09-30
    Survey response — days 1–6 daily, dose 3
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2024-11 · check-in free text available
  24. 2021-10-01
    Survey response — day 7, dose 3
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2024-11 · check-in free text available
  25. 2021-10-08
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  26. 2021-10-15
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  27. 2021-10-22
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  28. 2021-10-29
    Survey response — day 35, dose 3
    MedDRA: Asthenia, Dizziness, Erythema — Feeling: Fair
    Free text: On two occasions I have felt like I was going to faint and had to sit down. I have also noticed once that my skin color was more red like from being in the sun. In both instances it did not last long and I felt fine afterwards, other than being weak.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-11-05
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  30. 2021-12-24
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  31. 2022-03-25
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  32. 2022-03-30
    Dose 4 — Pfizer-BioNTech
  33. 2022-03-30
    Health check-in — day 0, dose 4
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  34. 2022-03-31
    Survey response — days 1–6 daily, dose 4
    MedDRA: Rash — Feeling: Good · Site: Pain
    Free text: Previous rash now gone.
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-04-01
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  36. 2022-04-02
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  37. 2022-04-03
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Diarrhea
    Adult check-in
  38. 2022-04-04
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  39. 2022-04-05
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  40. 2022-04-06
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  41. 2022-04-13
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  42. 2022-04-20
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  43. 2022-04-27
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  44. 2022-05-04
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  45. 2022-05-11
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  46. 2022-06-29
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  47. 2022-09-15
    Dose 5 — Pfizer-BioNTech
    Co-administered: Flu
  48. 2022-09-15
    Survey response — day 0, dose 5
    MedDRA: No adverse event — Feeling: Good
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-09-16
    Survey response — days 1–6 daily, dose 5
    MedDRA: No adverse event — Feeling: Good · Site: Pain · Fever
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-09-17
    Survey response — days 1–6 daily, dose 5
    MedDRA: No adverse event — Feeling: Good · Site: Redness, Itching
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  51. 2022-09-18
    Survey response — days 1–6 daily, dose 5
    MedDRA: No adverse event — Feeling: Good · Site: Redness
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  52. 2022-09-19
    Survey response — days 1–6 daily, dose 5
    MedDRA: No adverse event — Feeling: Good
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  53. 2022-09-20
    Survey response — days 1–6 daily, dose 5
    MedDRA: No adverse event — Feeling: Good
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  54. 2022-09-21
    Survey response — days 1–6 daily, dose 5
    MedDRA: No adverse event — Feeling: Good
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  55. 2022-09-22
    Survey response — day 7, dose 5
    MedDRA: No adverse event — Feeling: Good
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  56. 2022-09-29
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  57. 2022-10-06
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  58. 2022-10-13
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  59. 2022-10-20
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  60. 2022-10-27
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  61. 2022-12-15
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  62. 2023-03-16
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in
  63. 2023-04-26
    Dose 6 — Pfizer-BioNTech
  64. 2023-04-27
    Survey response — days 1–6 daily, dose 6
    MedDRA: No adverse event — Feeling: Good · Site: Pain
    MedDRA releases: 2024-11
  65. 2023-04-28
    Survey response — days 1–6 daily, dose 6
    MedDRA: No adverse event — Feeling: Good
    MedDRA releases: 2024-11
  66. 2023-04-29
    Survey response — days 1–6 daily, dose 6
    MedDRA: No adverse event — Feeling: Good
    MedDRA releases: 2024-11
  67. 2023-04-30
    Survey response — days 1–6 daily, dose 6
    MedDRA: No adverse event — Feeling: Good
    MedDRA releases: 2024-11
  68. 2023-05-01
    Survey response — days 1–6 daily, dose 6
    MedDRA: No adverse event — Feeling: Good
    MedDRA releases: 2024-11
  69. 2023-05-02
    Survey response — days 1–6 daily, dose 6
    MedDRA: No adverse event — Feeling: Good
    MedDRA releases: 2024-11
  70. 2023-05-03
    Survey response — day 7, dose 6
    MedDRA: No adverse event — Feeling: Good
    MedDRA releases: 2024-11
  71. 2023-05-10
    Health check-in — day 14, dose 6
    Feeling: Good
    Adult check-in
  72. 2023-05-17
    Health check-in — day 21, dose 6
    Feeling: Good
    Adult check-in
  73. 2023-05-24
    Health check-in — day 28, dose 6
    Feeling: Good
    Adult check-in
  74. 2023-05-31
    Health check-in — day 35, dose 6
    Feeling: Good
    Adult check-in
  75. 2023-06-07
    Health check-in — day 42, dose 6
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-10Pfizer-BioNTech
22021-03-03Pfizer-BioNTech
32021-09-24Pfizer-BioNTech No
42022-03-30Pfizer-BioNTech No
52022-09-15Pfizer-BioNTech Flu
62023-04-26Pfizer-BioNTech No

Free text

Release 7 — day 35, dose 2

2021-04-07

Symptoms: Experienced Vertigo when getting out of bed , but used Epley Maneuver to abate symptoms. After three days, Vertigo was completely gone, and no more dizziness.

Release 9 — day 0, dose 3

2021-09-24

Systemic reaction (other): None

Release 9 — days 1–6 daily, dose 3

2021-09-25

Systemic reaction (other): None

2021-09-26

Systemic reaction (other): None

2021-09-27

Systemic reaction (other): None

2021-09-28

Systemic reaction (other): None

2021-09-29

Systemic reaction (other): None

2021-09-30

Systemic reaction (other): None

Release 9 — day 7, dose 3

2021-10-01

Systemic reaction (other): None

Release 10 — day 35, dose 3

2021-10-29

Symptoms: On two occasions I have felt like I was going to faint and had to sit down. I have also noticed once that my skin color was more red like from being in the sun. In both instances it did not last long and I felt fine afterwards, other than being weak. cut off by CDC

Release 11 — days 1–6 daily, dose 4

2022-03-31

Systemic reaction (other): Previous rash now gone.

Release 12 — day 0, dose 5

2022-09-15

Release 12 — days 1–6 daily, dose 5

2022-09-16

2022-09-17

2022-09-18

2022-09-19

2022-09-20

2022-09-21

Release 12 — day 7, dose 5

2022-09-22

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthenia · · ✓
SDDizziness ✓ ✓ ✓
SDErythema · · ✓
SDVertigo ✓ ✓ ✓
SRONo adverse event · · ✓
SRORash · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…